# Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia

Study · id `cardio:ct-nct01401647` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01401647](<https://clinicaltrials.gov/study/NCT01401647>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01401647

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3024 participants.

## Technical summary

Registry record NCT01401647. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2017-01-30.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 3024 participants (enrolled count; ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Completion: 2016-01 (actual) (ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Results first posted: 2017-01-30 (ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01401647, source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01401647-2017-04-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
- Acronym: ALPS
- Condition: Cardiac Arrest
- Intervention (Drug): amiodarone
- Intervention (Drug): Lidocaine
- Intervention (Other): Normal saline
- Lead sponsor: University of Washington
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Heart and Stroke Foundation of Canada
- Collaborator class: OTHER
- Collaborator: American Heart Association
- Collaborator class: OTHER
- Collaborator: Defence Research and Development Canada
- Collaborator class: INDUSTRY
- Collaborator: U.S. Army Medical Research and Development Command
- Collaborator class: FED

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry intervention name matches this record: Amiodarone (`cardio:amiodarone`)
- Registry lists this organization as the lead sponsor: University of Washington (`cardio:org-university-of-washington`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)
- Registry lists this organization as a collaborator: Heart and Stroke Foundation of Canada (`cardio:org-heart-and-stroke-foundation-of-canada`)
- Registry lists this organization as a collaborator: American Heart Association (`core:aha`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest (`cardio:pubmed-27043165`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo) (`cardio:pubmed-28904070`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0f22561e8e470ce4278cb875577ef0d65c987bff664a9755d2bd3d3fef9cf96b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
